Welcome to the Bacteriophage Therapy Summit
With increasing regulatory flexibility for phage-based applications, address critical questions to help your phage technologies advance through commercial development
The Bacteriophage Therapy Summit is the definitive gathering for global phage experts. Focusing on human health and disease, the 4th Bacteriophage Therapy Summit focused on helping the industry advance their phage-based therapies through clinical development and commercialization beyond compassionate use.
2022 Agenda Tackled
Navigated clinical trial rationale, distribution effects of formulation on reaching infection sites, lessons learned from compassionate use trials, and the regulatory pathway for commercial development with the hottest insights from our 35+ expert speaker faculty
Held talks from international organizations including the FDA, BiomX, Locus Bioscience, Felix Bioscience, Phagomed, PhagePro, Cytophage, Sciphage and united the phage community prioritizing human health and disease
Discussed strategies to weaponize phage therapies including lysins, genetic engineered and combination approaches to create new pathways for the treatment of infectious diseases, across 3 days of unparalleled, industry-centered content